GLOTTIS CARCINOMA

This adverse event was reported 39 times

GLOTTIS CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CIDOFOVIR ANHYDROUS 1 0.0007
1 WHITE PETROLATUM 1 0.0007
2 BARICITINIB 1 0.0003
3 CLINDAMYCIN PHOSPHATE 1 0.0002
4 BASILIXIMAB 2 0.0002
5 GOLIMUMAB 1 0.0001
6 SUVOREXANT 1 0.0001
7 BISACODYL SUPPOSITORIES 1 0.0001
8 BISCODYL 1 0.0001
9 INDOMETHACIN 1 0.0001
See all drugs enriched for association with GLOTTIS CARCINOMA

GLOTTIS CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Stimulant Laxative [EPC] 1 0.0001
2 Orexin Receptor Antagonist [EPC] 1 0.0001
3 PCSK9 Inhibitor [EPC] 1 0.0000
4 Penem Antibacterial [EPC] 1 0.0000
5 Interleukin-17A Antagonist [EPC] 1 0.0000
6 Polyene Antifungal [EPC] 1 0.0000
7 Alkylating Drug [EPC] 6 0.0000
8 Protease Inhibitor [EPC] 1 0.0000
9 Aminoglycoside Antibacterial [EPC] 1 0.0000
See all drug classes enriched for association with GLOTTIS CARCINOMA